Kilmarnock striker Bruce Anderson and former Celtic midfielder Scott Allan, both living with type 1 diabetes, discuss their inspiring journeys in football and how the condition hasn’t stopped them from achieving their dreams. Their story highlights the importance of support, perseverance, and managing the condition effectively to thrive in any field.
Type-1 diabetes occurs when the immune system attacks and destroys beta cells in the pancreas, leading to insulin deficiency. Researchers are exploring ways to replace and protect transplanted beta cells from immune rejection, offering hope for a potential cure for the condition.
A Calgary mother is honoring her daughter’s memory and inspiring others to spread kindness through the Kelsey’s Day of Kindness initiative. Ten years after losing her daughter, Kelsey Roberts, to complications from Type 1 diabetes, Cheryl Mihaljevich continues her daughter’s legacy of helping others. Kelsey’s passion for baking led to the establishment of a baking cupboard at Ronald McDonald House in Calgary, where every spring, her family and supporters donate baking supplies in her name. The initiative also encourages acts of kindness, transforming Kelsey’s birthday into a day where people can make a positive difference in the lives of others.
Vertex Pharmaceuticals has partnered with TreeFrog Therapeutics to obtain an exclusive license to TreeFrog’s proprietary cell manufacturing technology, C-Stem. This collaboration aims to optimize the production of Vertex’s cell therapies for type 1 diabetes (T1D). TreeFrog’s technology is designed to mimic the natural microenvironment, allowing cells to grow exponentially in 3D. By scaling up TreeFrog’s process, Vertex will be able to generate large amounts of fully differentiated cells for its T1D therapies.
